EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2024-10-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024

46

2024-09-27

NEXT DAY DISCLOSURE RETURN

75

2024-09-17

NEXT DAY DISCLOSURE RETURN

131

2024-09-16

NEXT DAY DISCLOSURE RETURN

129

2024-09-13

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE SODIUM HYALURONATE EYE DROPS (0.3%) IN THE PRC

128

2024-09-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024

173

2024-09-02

NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS

159

2024-09-02

NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS

129

2024-08-27

NEXT DAY DISCLOSURE RETURN

165

2024-08-26

INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024

158

2024-08-26

INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024

172

2024-08-14

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE DIQUAFOSOL SODIUM EYE DROPS IN THE PRC

214

2024-08-14

NOTICE OF BOARD MEETING

202

2024-08-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024

254

2024-07-31

VOLUNTARY ANNOUNCEMENT REPAYMENT OF CONVERTIBLE LOAN FROM INTERNATIONAL FINANCE CORPORATION

286

2024-07-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024

376

2024-06-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

497

2024-05-28

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2024

511

2024-05-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024

582

2024-04-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

643

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT